Stay updated on Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page.

Latest updates to the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.6.5 is now shown, replacing the previous Revision: v3.6.4. This suggests a minor platform update rather than a substantive change to the study details.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe Revision tag changed from v3.6.3 to v3.6.4. This appears to be a minor update to the publication or site software, with no visible changes to content or features.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision: v3.6.3 is now displayed, signaling a minor update to the page content or metadata since the previous revision (v3.6.2). The change does not affect the study data or eligibility.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded a 2026 publication by Paller et al. reporting ECZTRA 6 results in Dermatol Ther (Heidelb) and removed the earlier 'Online ahead of print' citation dated Apr 25, 2026 (doi: 10.1007/s13555-026-01745-7). The page revision was updated to v3.6.2.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page adds new user guidance pages (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the header from 'Intervention / Treatment' to 'Intervention/Treatment', while updating the revision to v3.6.0.SummaryDifference0.2%

- Check76 days agoChange DetectedThe page footer revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page's metadata. The change does not alter any study information or content presented to users.SummaryDifference0.0%

Stay in the know with updates to Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page.